Cingulate Inc Warrants (CINGW) had the highest return on August 8, 2023 by a US stock, returning 82.9%.

ASSET	DATE	% RETURN
Cingulate Inc Warrants (CINGW)	8/8/2023	82.85%
NLS Pharmaceutics (NLSPW)	8/8/2023	63.29%
BuzzFeed (BZFDW)	8/8/2023	61.87%
error (ZVZZT)	8/8/2023	54.37%
Palladyne AI (PDYNW)	8/8/2023	48.18%
Netcapital (NCPLW)	8/8/2023	32.08%
Nutriband Inc Warrant (NTRBW)	8/8/2023	30.61%
Cardiff Oncology (CRDF)	8/8/2023	30.54%
Renovaro Biosciences (RENB)	8/8/2023	27.82%
Helport AI Limited Warrants (HPAIW)	8/8/2023	26.43%
Triller (ILLRW)	8/8/2023	25%
Oncology Institute (TOIIW)	8/8/2023	25%
MIRA Pharmaceuticals, Inc Common Stock (MIRA)	8/8/2023	24.43%
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW)	8/8/2023	24.35%
Tilray (TLRY)	8/8/2023	23.27%
Telephone and Data Systems (TDS)	8/8/2023	22.14%
Capricor Therapeutics (CAPR)	8/8/2023	21.66%
Xtant Medical (XTNT)	8/8/2023	21.5%
BranchOut Food Inc Common Stock (BOF)	8/8/2023	20.67%
Cipher Mining (CIFRW)	8/8/2023	20%
Aurora Innovation (AUROW)	8/8/2023	19.97%
Inspirato (ISPO)	8/8/2023	18.81%
Electrocore LLC (ECOR)	8/8/2023	18.2%
Milestone Pharmaceuticals (MIST)	8/8/2023	18.03%
LMF Acquisition Opportunities (ICUCW)	8/8/2023	18%